期刊文献+

一步法合成(R)-α-硫辛酸 被引量:2

One-step Process of(R)-α-Lipoic Acid Synthesis
在线阅读 下载PDF
导出
摘要 为提高(R)-α-硫辛酸(Ⅱ)合成收率,降低生产成本,以R体α-甲基苄胺拆分6,8-二氯辛酸得到的(R)-6,8-二氯辛酸(Ⅰ)为原料,在水相中采用一步法合成Ⅱ。讨论了摩尔比、反应温度、滴加时间等诸因素对产物收率及比旋光度的影响,获得了较优合成条件:拆分反应中,n(6,8-二氯辛酸)∶n〔(R)-α-甲基苄胺〕=1∶0.48,反应温度35℃,盐酸酸化;取代反应中,n(Ⅰ)∶n(二硫化钠)=1∶1.2,反应温度75℃,滴加时间3.0 h。在该优化条件下,Ⅱ的总收率为30.0%,并在该条件下,将6,8-二氯辛酸投料量扩大至600 g,Ⅰ投料量扩大至222.0 g,所得Ⅱ平均总收率可达34.3%。 To increase the yield of (R)-α-lipoic acid ( Ⅱ) and reduce its cost,an one-step synthesis of Ⅱ by using (R)-6,8-dichlorooctanoic acid ( Ⅰ ) as starting material was described. The synthesis steps involved chiral resolution of 6, 8-dichlorooctanoic acid by (R)-α-phenylethylamine and substitution reaction in water phase. The optimized parameters were as follow. In the chiral resolution, n (6,8-dichlorooctanic acid) :n [ (R)-α-phenylethylamine ]= 1:0. 48, and reaction temperature is 35 ℃ ; in the substitution reaction, n ( Ⅰ ) : n ( Na2S2 ) = 1 : 1.2, the reaction temperature is 75℃, and the dropping time keeps 3.0 h. Under the optimal conditions, the total yield of Ⅱ was 30.0%. When starting material 6,8-dichlorooctanic acid was expanded to 600 g and Ⅰ was increased to 222.0 g, the total yield of Ⅱ was up to 34.3%.
出处 《精细化工》 EI CAS CSCD 北大核心 2007年第10期991-995,共5页 Fine Chemicals
基金 贵州省工业攻关项目(黔科合2004GGY021)~~
关键词 (R)-α-硫辛酸 (R)-6 8-二氯辛酸 拆分 医药原料 (R) -α-lipoic acid (R) -6,8-dichlorooctanic acid chiral resolution drug materials
  • 相关文献

参考文献15

  • 1Reed L, Debusk B, Gunsalus I. Crystalline alpha-lipoic acid : a catalytic agent associated with pyruvate dehydrogenase [ J ]. Science, 1951,114 (2952) :93 - 94.
  • 2Yasunori B. α-Lipoic acid [ J]. New Food Industry,2005,47 (4) : 9 -15.
  • 3Norbert M, Jeanine K, Jens T,et al. Cosmetic preparation containing oxidation-sensitive active substances and metaleomplexing agents for stability [P]. DE:102 005 004 187A1,2006 - 08 - 10.
  • 4国家药典委员会编.中华人民共和国药典[M].第2部.北京:化学工业出版社,2005.355.
  • 5Rieks A, Kaehler M,Kirchner U, et al. Preparation of novel curcumin/tetrahydrocurcumin derivatives for use in cosmetics pharmaceuticals and for nutrition [ P]. WO: 2004 031 122A1 2004 - 03 - 11.
  • 6Roberto C, Marco B, Daniele G. Pharmaceutical or nutraceutical compositions containing chromium or iron complexes of alpha-lipoic acid [ P ]. WO : 2006 048 911A2,2006 -05 - 11.
  • 7Sudalai A, Upadhya T T, Nikalaje M D,et al. Asymmetric dihydroxylation and hydrogenation approaches enantioselective synthesis of R-( + )-α-lipoic acid Tetrahedron Letters ,2001,42 (29) : 4891 - 4893. to the [J].
  • 8Zimmer R, Peritz A, Czerwonka R, et al. Optimisation, scope and limitations of enantioselective aldol reactions of an S-ketene silyl acetal with aliphatic aldehydes under ( R ) -BINOL-titanium (Ⅳ) catalysis conditions [ J ]. European Journal of Organic Chemistry, 2002,20:3419 - 3428.
  • 9孙菁,王旻,陈代杰.R-(+)-硫辛酸关键手性中间体的微生物转化进展[J].药物生物技术,2002,9(3):165-170. 被引量:8
  • 10Annibale S, Stefano M, Francesco C. Process for the production of a racemic thioctic acid [ P]. US:2005 6 844 450,2005 -01 -18.

二级参考文献1

共引文献7

同被引文献48

  • 1徐常龙,曹小华,陶春元,张康华,谢宝华,张爱东.α-硫辛酸-(8-生物素酰胺基-3,6-二氧辛基)酰胺的合成[J].江西师范大学学报(自然科学版),2008,32(4):457-461. 被引量:1
  • 2顾正桂.连续逆流液液萃取分离二硫辛酸与乙醇及碱水溶液的方法,中国专利,1807424A[P].2006-07-26.
  • 3Packer L, Kraemer K, Pdmbacb G. Molecular aspects of li- poic acid in the prevention of diabetes complication [ J ]. Nutrition ,2001,17 : 888-895.
  • 4Biewenga G P, Haenen G R, Bast A. The pharmacology of the antioxidant [ J ]. General Pharmacology, 1997,29 ( 3 ) : 315-331.
  • 5Bustamante J, Lodge J K, Marcocci L, et al. Alpha-lipoic acid in liver metabolism and disease [ J ]. Free Radic Biol Med, 1998,24 (6) : 1023-1039.
  • 6Samantha B, Pimgruber G D, Roe1 P. Influence of the properties of zeolite BEA on its performance in the nitra- tion of toluene and nitrotoluene [ J ]. J Catal, 2004 : 297- 303.
  • 7Wincenty S,Monika M. Nitration of toluene with 65% ni- tric acid over MoO3/SiO2 as catalyst [ J ]. Przem Chem, 2002,81 (8) :519-521.
  • 8Ahmed H H. Modulatory effects of vitamin E, acetyl-1- carnitine and a-lipoic acid on new potential biomarkers for Alzheimer' s disease in rat model [ J ]. Experimental and Toxicologic Pathology ,2011 (10) :1-8.
  • 9Baur A, Harrer T, Peukert M, et al. Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication [ J ]. Klin Wochenschr, 1991,69 ( 15 ) :722-724.
  • 10Bezbarua M S,Saikia A K,Barua N C, et al. A short en- antioselective formal synthesis of methyl (S)-( - )-6,8- di-hydroxyoctanoate:a key intermediate for the synthesis of R- ( + ) -a-lipoic acid [ J ]. Synthesis, 1996 ( 11 ) : 1289- 1290.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部